These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
973 related articles for article (PubMed ID: 23811400)
1. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses. Aleshin S; Strokin M; Sergeeva M; Reiser G Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels. Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106 [TBL] [Abstract][Full Text] [Related]
3. Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain. Aleshin S; Reiser G Biol Chem; 2013 Dec; 394(12):1553-70. PubMed ID: 24021597 [TBL] [Abstract][Full Text] [Related]
4. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists. Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681 [TBL] [Abstract][Full Text] [Related]
5. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells. Sergeeva MG; Aleshin SE; Grabeklis S; Reiser G J Neurochem; 2010 Oct; 115(2):399-410. PubMed ID: 20670373 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]